Invokana
Invokana Settlement Update
Invokana is a sodium-glucose co-transporter-2 (SGLT2) inhibitor for Type 2 Diabetics manufactured by Janssen.The Invokana class action has settled.The Settlement provides for the payment of $1,500,000 which will be used to pay approved claims. The claims period has now passed, as of August 14, 2023 and no further claims are being accepted. We are presently waiting for settlement funds to be paid to our clients who successfully claimed.
Jardiance is a similar drug manufactured by Boehringer. The claim as related to Jardiance has been abandoned by the class action lawyers as there were not enough users in Canada. We are not accepting any new cases and no further claims related to this drug may be made.
Symptoms of Ketoacidosis
- Flushed, hot, dry skin.
- Blurred vision.
- Feeling thirsty and urinating a lot.
- Drowsiness or difficulty waking up. Young children may lack interest in their normal activities.
- Rapid, deep breathing.
- A strong, fruity breath odor.
- Loss of appetite, belly pain, and vomiting.
- Confusion.
Other conditions associated with this drug include bladder infection, heart arrhythmia, heart attack, cardiac arrest, brain aneurism, kidney disease, or failure. If you are taking any of these medications now please consult your doctor right away to see if you should switch to another medication for control of diabetes. You can not just stop without having serious consequences.
Invokana Diabetes Drug Lawsuit
Factors That Increase Your Likelihood of Having Medical Problems by Taking Invokana
About Daniel J. Miskin
Contact
Peterborough: 705-755-7363 ext. 2
Toll Free: 1-877-428-8000 ext. 2